Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Non-Current Deferred Tax Liability (2022 - 2023)

RxSight filings provide 2 years of Non-Current Deferred Tax Liability readings, the most recent being $646000.0 for Q4 2023.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 44.45% to $646000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $646000.0, a 44.45% decrease, with the full-year FY2023 number at $646000.0, down 44.45% from a year prior.
  • Non-Current Deferred Tax Liability hit $646000.0 in Q4 2023 for RxSight, down from $1.2 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.2 million in Q4 2022 to a low of $646000.0 in Q4 2023.